BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 33163196)

  • 1. Low prevalence of mismatch repair deficiency in Chinese colorectal cancers: a multicenter study.
    Jiang W; Sui QQ; Li WL; Ke CF; Ling YH; Liao LE; Zhu Z; Cai MY; Luo J; Mao LL; Zhang HZ; Wan DS; Pan ZZ; Ju HX; Ding PR
    Gastroenterol Rep (Oxf); 2020 Oct; 8(5):399-403. PubMed ID: 33163196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential predictors for CDX2 expression loss and mismatch repair deficiency in colorectal cancer.
    Vlahović I; Rajc J; Švagelj I; Šolić K; Švagelj D
    Pathol Oncol Res; 2023; 29():1610908. PubMed ID: 37325467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic characteristics of resectable colorectal cancer with mismatch repair protein defects in Chinese population: Retrospective case series and literature review.
    Li J; Xu Q; Luo C; Chen L; Ying J
    Medicine (Baltimore); 2020 Jun; 99(24):e20554. PubMed ID: 32541478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression status of four mismatch repair proteins in patients with colorectal cancer: clinical significance in 1238 cases.
    Chen L; Chen G; Zheng X; Chen Y
    Int J Clin Exp Pathol; 2019; 12(10):3685-3699. PubMed ID: 31933757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the Clinicopathological Characteristics of Stage I-III Colorectal Cancer Patients Deficient in Mismatch Repair Proteins.
    Liang Y; Cai X; Zheng X; Yin H
    Onco Targets Ther; 2021; 14():2203-2212. PubMed ID: 33814918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mismatch Repair Deficient (dMMR) Colorectal Carcinoma in a Pakistani Cohort: Association With Clinical and Pathological Parameters.
    Hashmi AA; Bukhari U; Rizwan R; Faisal F; Kumar R; Malik UA; Zia S; Khan AR; Sham S; Irfan M
    Cureus; 2023 Aug; 15(8):e42781. PubMed ID: 37664303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Difference analysis of somatic mutations between deficient mismatch repair and proficient mismatch repair gene related with colorectal cancer].
    Tang XJ; Yang MY; Zhu LZ; Xu D; Yuan Y
    Zhonghua Zhong Liu Za Zhi; 2021 Oct; 43(10):1088-1093. PubMed ID: 34695900
    [No Abstract]   [Full Text] [Related]  

  • 8. Real-world outcome of universal screening for Lynch syndrome in Japanese patients with colorectal cancer highlights the importance of targeting patients with young-onset disease.
    Yamada A; Matsuoka Y; Minamiguchi S; Yamamoto Y; Kondo T; Sunami T; Horimatsu T; Kawada K; Seno H; Torishima M; Murakami H; Yamada T; Kosugi S; Sugano K; Muto M
    Mol Clin Oncol; 2021 Dec; 15(6):247. PubMed ID: 34712484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Association of status of mismatch repair protein expression and EB virus infection with clinicopathological parameters in 886 gastric adenocarcinoma patients].
    Liu Y; Zang FL; Qiu ZQ; Guo YH; Luo Y; Sun L; Zhao S; Shao B; Liang H; Sun Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 May; 24(5):440-448. PubMed ID: 34000774
    [No Abstract]   [Full Text] [Related]  

  • 10. Mismatch repair deficiency screening in colorectal carcinoma by a four-antibody immunohistochemical panel in Pakistani population and its correlation with histopathological parameters.
    Hashmi AA; Ali R; Hussain ZF; Faridi N; Khan EY; Bakar SMA; Edhi MM; Khan M
    World J Surg Oncol; 2017 Jun; 15(1):116. PubMed ID: 28651545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlation between mismatch-repair protein expression and clinicopathologic features in 658 colorectal cancers].
    Hu XR; Xu C; Kang Y; Wang T; Zhang Y; Yang XH
    Zhonghua Bing Li Xue Za Zhi; 2018 Nov; 47(11):827-833. PubMed ID: 30423605
    [No Abstract]   [Full Text] [Related]  

  • 12. KRAS and BRAF gene mutations and DNA mismatch repair status in Chinese colorectal carcinoma patients.
    Ye JX; Liu Y; Qin Y; Zhong HH; Yi WN; Shi XY
    World J Gastroenterol; 2015 Feb; 21(5):1595-605. PubMed ID: 25663779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological features of mismatch repair protein expression patterns in colorectal cancer.
    Lee CT; Chow NH; Chen YL; Ho CL; Yeh YM; Lin SC; Lin PC; Lin BW; Chu CA; Tsai HW; Lee JC
    Pathol Res Pract; 2021 Jan; 217():153288. PubMed ID: 33276219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Both MLH1 deficiency and BRAFV600E mutation are a unique characteristic of colorectal medullary carcinoma: An observational study.
    Kaneko M; Nakashima M; Sugiura K; Ishida N; Tamura S; Tani S; Yamade M; Hamaya Y; Osawa S; Tatsuta K; Kurachi K; Baba S; Iwashita Y; Arai T; Sugimura H; Maekawa M; Sugimoto K; Iwaizumi M
    Medicine (Baltimore); 2023 Sep; 102(38):e35022. PubMed ID: 37746995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mismatch repair protein expression of colorectal cancer: a retrospective analysis of 3 428 cases].
    Liu Y; Guo YH; Luo Y; Sun L; Zhao S; Shao B; Zang FL; Qiu ZQ; Sun BC; Sun Y
    Zhonghua Bing Li Xue Za Zhi; 2021 Apr; 50(4):369-375. PubMed ID: 33831997
    [No Abstract]   [Full Text] [Related]  

  • 16. [Correlation of NTRK genetic fusions with mismatch repair protein deletion in patients with colorectal cancer].
    Pu XH; Gao FP; Wu HY; Fu Y; Fan XS
    Zhonghua Bing Li Xue Za Zhi; 2022 Feb; 51(2):103-107. PubMed ID: 35152627
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunohistochemistry for PMS2 and MSH6 alone can replace a four antibody panel for mismatch repair deficiency screening in colorectal adenocarcinoma.
    Hall G; Clarkson A; Shi A; Langford E; Leung H; Eckstein RP; Gill AJ
    Pathology; 2010; 42(5):409-13. PubMed ID: 20632815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in genetic technologies result in improved diagnosis of mismatch repair deficiency in colorectal and endometrial cancers.
    Evans DG; Lalloo F; Ryan NA; Bowers N; Green K; Woodward ER; Clancy T; Bolton J; McVey RJ; Wallace AJ; Newton K; Hill J; McMahon R; Crosbie EJ
    J Med Genet; 2022 Apr; 59(4):328-334. PubMed ID: 33452216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemistry and microsatellite instability analysis in molecular subtyping of colorectal carcinoma based on mismatch repair competency.
    Yuan L; Chi Y; Chen W; Chen X; Wei P; Sheng W; Zhou X; Shi D
    Int J Clin Exp Med; 2015; 8(11):20988-1000. PubMed ID: 26885030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA Mismatch Repair-Deficient Colorectal Carcinoma: Referral Rate for Genetic Cancer Risk Assessment in a Brazilian Cancer Center.
    Gomes AAD; Macedo MP; Torrezan GT; Zenun GR; Aguiar S; Begnami MD; Carraro DM; Formiga MN
    J Gastrointest Cancer; 2021 Sep; 52(3):997-1002. PubMed ID: 32974876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.